News

Common treatment can wake up dormant cancer cells, causing the disease to spread from original sites to other organs, team discovers.
U.S. inspectors have uncovered new and dangerous breakdowns in drugmaking at an Indian factory owned by Sun Pharma that ...
The latest inspection comes 2 1/2 years after the agency allowed Sun Pharma to keep shipping some drugs to Americans even ...
The FDA issued a complete response letter to Genentech indicating it cannot approve the company’s biologic license ...
The SAHPRA has assured consumers that the cancer medication sold and marketed in the country meets the relevant health ...
Family doctors frequently encounter patients with vague and nonspecific symptoms, which are often attributed to common and ...
Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering artificial intelligence (AI) company transforming oncology drug discovery and development, today announced the launch of an innovative AI-powered ...
Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to lung adenocarcinoma cells, dramatically suppressing tumor growth in ...
Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers. It is a very heterogeneous disease, ...
D octors routinely warn their patients about the dangers of obesity and now, new research shows that it is also causing a ...
Chinese scientists discovered that chemotherapy could inadvertently trigger dormant cancer cells, potentially accelerating ...
Medically reviewed by Archana Sharma, DO There are several treatment options for multiple myeloma. Since this disease varies ...